About 293,000 results
Open links in new tab
  1.  
  2. Pegcetacoplan
    • According to 2 sources
    In February 2023, the US Food and Drug Administration (FDA) approved a new drug for the treatment of age-related macular degeneration (ARMD). The drug, pegcetacoplan (commercial name Syfovre™), is produced by Appelis Pharmaceuticals. This is the first drug approved for treatment of dry macular degeneration.
    In February we shared the exciting news that the first-ever drug to treat dry age-related macular degeneration (AMD) has been approved in the US. Pegcetacoplan, known as Syfovre, was cleared for use in patients by the Food and Drug Administration (FDA).
     
  3. People also ask
     
  4. FDA Approves First Geographic Atrophy Treatment SYFOVRE

  5. What to Know About Syfovre and Izervay for Geographic Atrophy

  6. FDA Approves New Drug for Macular Degeneration | Healthline

  7. Macular Degeneration Breakthroughs: Emerging …

    WEBMay 27, 2024 · Learn about the emerging treatments for wet age-related macular degeneration (AMD), such as retinal gene therapy, port delivery

    • Estimated Reading Time: 10 mins
    • New Treatments for Macular Degeneration on the Horizon

    • New Treatments for Age-Related Macular Degeneration

    • Alkeus Pharmaceuticals Announces Results from the SAGA Study …